SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001262463-14-000923
Filing Date
2014-10-14
Accepted
2014-10-14 09:59:55
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plpl10k2014.htm 10-K 493066
2 EXHIBIT 31.1 ex311.htm EX-31 7837
3 EXHIBIT 31.2 ex312.htm EX-31 7635
4 EXHIBIT 32.1 ex321.htm EX-32 4042
5 EXHIBIT 32.2 ex322.htm EX-32 4054
  Complete submission text file 0001262463-14-000923.txt   3972258

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE plpl-20140630.xml EX-101.INS 448323
7 XBRL SCHEMA FILE plpl-20140630.xsd EX-101.SCH 38230
8 XBRL CALCULATION FILE plpl-20140630_cal.xml EX-101.CAL 53016
9 XBRL DEFINITION FILE plpl-20140630_def.xml EX-101.DEF 179743
10 XBRL LABEL FILE plpl-20140630_lab.xml EX-101.LAB 264986
11 XBRL PRESENTATION FILE plpl-20140630_pre.xml EX-101.PRE 247909
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (435) 881-8734
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

IRS No.: 453642179 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-51206 | Film No.: 141154094
SIC: 2834 Pharmaceutical Preparations